Comparative Efficacy of PD‐1 Inhibitor‐Based Neoadjuvant Chemoimmunotherapy Regimens for Resectable Stage II–IIIa NSCLC: A Real‐World Retrospective Study

ABSTRACT Background Although neoadjuvant chemoimmunotherapy has emerged as a promising approach for resectable non‐small cell lung cancer (NSCLC), comparative real‐world data on different PD‐1 inhibitors are limited. This study compared the clinical efficacy, pathological response, survival, and saf...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Bo Yan, Xiaoxuan Sun, Yan Sheng, Ran Zhang, Yanjun Su, Yulong Chen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2025-07-01
Edice:	Thoracic Cancer
Témata:	chemoimmunotherapy immune checkpoint inhibitors neoadjuvant therapy non‐small cell lung cancer surgery
On-line přístup:	https://doi.org/10.1111/1759-7714.70123
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!